| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |